Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference
September 13, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in...
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 06, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in...
Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté
August 28, 2024 07:00 ET
|
Krystal Biotech, Inc.
Décolleté indication selected for Phase 2 study expected to start next year Conference call to discuss results scheduled for Wednesday, August 28, 2024 at 4:30 p.m. ET PITTSBURGH, Aug. 28, 2024...
Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates
August 05, 2024 08:00 ET
|
Krystal Biotech, Inc.
Net product revenue of $70.3 million in 2Q and $166.2 million since launch in August 2023 On track to deliver three clinical readouts in 2H 2024Jeune Aesthetics’ KB301 Phase 1...
Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024
July 26, 2024 08:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its second quarter...
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, June 05, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the...
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
May 15, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new...
Krystal Biotech to Present at BofA Securities 2024 Health Care Conference
May 08, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, May 08, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the...
Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates
May 06, 2024 08:00 ET
|
Krystal Biotech, Inc.
Net product revenue of $45.3 million in 1Q and $95.9 million since AugustFirst patient dosed in inhaled KB707 study for locally advanced or metastatic tumors of the lungReceived Fast Track...
Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
May 02, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, May 02, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new...